Key Insights

Highlights

Treatment Research

3 treatments under study, led by Automatic Detection And Segmentation Of Nsclc Tumors

Research Leaders

7 sponsors active, led by Royal North Shore Hospital

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Recruiting2
Unknown1

Clinical Trials (3)

Showing 3 of 3 trials
NCT06546592Not ApplicableRecruiting

Locally Optimised Contouring With AI Technology for Radiotherapy

NCT06646679RecruitingPrimary

Intelligent Segmentation Algorithm of Ultrasonic Image

NCT04164186Unknown

Fully Automated Pipeline for the Detection and Segmentation of Non-Small Cell Lung Cancer (NSCLC) on CT Images

Showing all 3 trials

Research Network

Common Treatments

  • Automatic Detection And Segmentation Of Nsclc Tumors1
  • Ai Assisted Contouring1
  • Ultrasonic Imaging1

Active Sponsors

  • Royal North Shore Hospital1
  • Affiliated Zhongshan Hospital of Dalian University, 6 Jiefang street, Dalian 116001, China1
  • Centre Hospitalier Universitaire de Liege1
  • Maastricht University1
  • Tongji Hospital1

Top Investigators

Related Conditions

  • Contouring1
  • Artificial Intelligence1
  • Deep Learning1
  • Detection1
  • Radiation Therapy1

Activity Timeline